Sunday, September 13, 2026

North Korea’s AI Strategy: How Kim Jong Un Plans to Use AI for National Survival in 2026

North Korea views AI as vital for regime survival, planning to institutionalize it as a national priority at the upcoming Party Congress.

7 Major Scandals Under Investigation: Will the Democratic Party Uncover the Truth?

The Democratic Party of Korea plans a national investigation into alleged manipulative prosecutions under the Yoon administration, focusing on seven key cases.

LA Dodgers’ Shohei Ohtani Snags Million Dollar Mansion Near Dodgers Stadium

Major League Baseball (MLB) superstar Shohei Ohtani...

Tag: agreement

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Alteogen Signs Subcutaneous Injection Development Deal With Novartis Worth Up to $3.22 Billion

Alteogen has signed an option and licensing agreement with Novartis to develop and commercialize subcutaneous formulations based on its ALT-B4 technology, with potential payments of up to $3.22 billion plus royalties.

Meta’s 16.7 Billion USD Settlement: What It Means for Teen Social Media Use

Meta agrees to enhance youth protection measures on Facebook and Instagram, addressing concerns over social media addiction among teens.

Alteogen Signs $365 Million License Deal With Global Pharma Company for SC Platform Technology

Alteogen has signed an exclusive licensing agreement with a global pharmaceutical company for the development of subcutaneous biopharmaceuticals.

AI-Powered Antibody Drug Development: Samsung Biologics and Protina’s Game-Changing License Agreement

Samsung Bioepis and Protina sign a licensing agreement to develop AI-designed antibody drugs, aiming for candidates by 2027.

Samsung Electro-Mechanics Secures 450 Million KRW MLCC Supply Deal for AI Servers: What This Means for the Tech Industry

Samsung Electro-Mechanics has signed a $290M deal for MLCCs for AI servers, aiming to expand its product portfolio and market share.

Huons Meditech Enters Japan’s Aesthetic Market With Exclusive Distribution Agreement for Dermashine Duo_RF

Huons Meditech enters Japan's aesthetic market with its Dermashine Duo_RF device, partnering with Nifuji for distribution and sales.

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Texas Dolce Project Marks New Step in Korea Southern Power’s North American Energy Storage Strategy

Korea Southern Power signed a joint development agreement for the Dolce BESS project in Texas with HD Hyundai Electric and others.

Curiosis Expands Revvity Partnership With 110 Billion KRW Supply Deal for Live-Cell Imaging Systems

Curiosis expands its partnership with Revvity, boosting a supply contract for live cell imaging systems to 110 billion KRW, enhancing market reach.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.